Status:
COMPLETED
Compare Propofol to Fentanyl and Midazolam for Colonoscopy
Lead Sponsor:
Trinity Health Michigan
Conditions:
Colon Cancer
Rectal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study aim is to determine if Propofol or the combination of Fentanyl and low-dose Midazolam, are equivalent for patient satisfaction and discomfort when undergoing a colonoscopy. This is a prospec...
Detailed Description
Background The use of colonoscopy has become an important diagnostic and therapeutic tool in the evaluation of multiple medical conditions of the gastrointestinal tract. Despite its widespread use, th...
Eligibility Criteria
Inclusion
- Age \> 18
- Elective outpatient colonoscopy
- American Society of Anesthesiology Class (ASA) \< IV
Exclusion
- Age \< 18
- Inpatient status
- Emergency procedure
- History of colonic or rectal resection
- History of hypersensitivity to Propofol (or soy or egg products),Fentanyl or Midazolam
- ASA of IV
- Neurological deficit
- Acute gastrointestinal bleeding
- On anticoagulation agents
- Noncompliance with bowel regiment
- Pregnant women
- Prisoners
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
289 Patients enrolled
Trial Details
Trial ID
NCT01488045
Start Date
June 1 2011
End Date
March 1 2015
Last Update
May 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint Joseph Mercy Hospital
Ann Arbor, Michigan, United States, 48106